Tidmarsh's appointment as the agency's top drug regulator could be announced as soon as Monday, the report said, citing the ...

Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt ...

The U.S. Food and Drug Administration (FDA) announced last week that it had approved a new blue food dye derived from the fruit of the Gardenia plant. The additive is approved for use in sports drinks ...

Food and Drug Administration (FDA) Commissioner Dr. Marty Makary talked about the actions the agency has taken during his first 100 days in office and related goals during his tenure.

Bloomage, a global leader in hyaluronic acid and other bioactive substance innovations, has announced it successfully passed ...

By Sriparna Roy and Sneha S K (Reuters) -The U.S. Food and Drug Administration said on Monday it has appointed former biotech executive George Tidmarsh as the director of the Center for Drug ...

Sarepta stock has tanked. Most investors don’t see the drugmaker’s executive management as credible following the failure to disclose a patient death, a BMO survey suggests.

Sarepta stock took another dive Monday after the biotech company refused the FDA's request to voluntarily stop all shipments ...

A massive FDA deodorant recall was issued for 67,000 Power Stick items. The agency highly urges consumers to avoid using the ...

Investing.com -- Sarepta Therapeutics Inc (NASDAQ: SRPT) stock tumbled 10% following the announcement that the U.S. Food and Drug Administration has placed a clinical hold on the company’s ...

Next time you reach for a can of olives at the shops, you might want to have a closer look at what's actually in there.

A voluntary recall has been announced for nearly 70,000 cases of deodorant sold at Walmart, Amazon and Dollar Tree.